Showing results (11-20 of 2,325) with videos related to
Sort By:
Pageof 233
Leukemia & Lymphoma|February 16, 2000
Histamine as an autocrine regulator of leukemic cell proliferationR Malaviya, F M UckunLeukemia & Lymphoma|September 24, 1999
A critical risk-benefit assessment argues against the use of anthracyclines in induction regimens for newly diagnosed childhood acute lymphoblastic leukemiaY Messinger, F M UckunAmerican Journal of Therapeutics|September 11, 2001
Leflunomide metabolite analogue alpha-cyano-beta-hydroxy-beta-methyl-N-[3-(trifluoromethyl)phenyl]propenamide inhibits IgE/FcepsilonRI receptor-mediated mast cell leukotriene release and allergic asthma in miceR Malaviya, F M UckunLeukemia|February 1, 1993
The current status of immunotoxins: an overview of experimental and clinical studies as presented at the Third International Symposium on ImmunotoxinsF M Uckun, A FrankelBiochemical and Biophysical Research Communications|April 20, 1999
Genetic and biochemical evidence for a critical role of Janus kinase (JAK)-3 in mast cell-mediated type I hypersensitivity reactionsR Malaviya, F M UckunClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agentsE A Sudbeck, X P Liu, R K Narla, et al.Human Reproduction Update|December 3, 1999
Prophylactic contraceptives for HIV/AIDSF M Uckun, O J D'CruzToxicological Sciences : an Official Journal of the Society of Toxicology|March 15, 2001
Short-Term (13-week) toxicity study of 5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent, in B6C3F1 miceO J D'Cruz, F M UckunJournal of Applied Toxicology : JAT|August 2, 2001
Bis(4,7-dimethyl and 5-dinitro-1,10-phenanthroline) sulfato-oxovanadium(IV)-mediated in vivo male germ cell apoptosisO J D'Cruz, F M UckunPharmacology & Therapeutics|January 1, 1992
Pokeweed antiviral protein: ribosome inactivation and therapeutic applicationsJ D Irvin, F M UckunPageof 233